NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX), Five9, Inc. (NASDAQ: FIVN), DMC Global Inc. (NASDAQ: BOOM), and Marqeta, Inc. (NASDAQ: MQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Kyverna Therapeutics, Inc. (NASDAQ: KYTX)

Class Period: Kyverna securities pursuant and/or traceable to the Company's offering documents issued in connection with its initial public offering ("IPO") conducted on February 8, 2024

Lead Plaintiff Deadline: February 7, 2025

According to the Complaint, the Company made false and misleading statements to the market. Kyverna was in possession of adverse data related to one of its ongoing trials. The Company’s lead product was negatively impacted by the undisclosed adverse data, which made the trends and disclosed results in the offering documents misleading. The Company’s discussion of risk factors failed to adequately describe the risk of it withholding clinical data. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Kyverna, investors suffered damages.

For more information on the Kyverna class action go to: https://bespc.com/cases/KYTX

Five9, Inc. (NASDAQ: FIVN)

Class Period: June 4, 2024 - August 8, 2024

Lead Plaintiff Deadline: February 3, 2025

According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Five9’s net new business was not “strong irrespective of the macro” and was, in fact, hampered by macroeconomic issues such as constrained and scrutinized customer budgets; (2) Five9 was in the midst of a challenging bookings quarter due, in part, to sales execution and efficiency issues, and Five9 was not “seeing very strong bookings momentum”; and (3) defendants did not have “enough information in terms of [their] existing customers that are going live” such that the statements that Five9 would see a positive inflection in its dollar-based retention rate lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

For more information on the Five9 class action go to: https://bespc.com/cases/FIVN

DMC Global Inc. (NASDAQ: BOOM)

Class Period: May 3, 2024 - November 4, 2024

Lead Plaintiff Deadline: February 4, 2025

The complaint alleges that, throughout the Class Period, defendants made materially false and misleading statements and failed to disclose the following adverse facts about DMC Global’s business, operations, and prospects which were known to defendants or recklessly disregarded by them: (i) the goodwill associated with the company’s principal business segment, Acadia Products, was overstated due to the adverse events and circumstances affecting that reporting segment; (ii) DMC Global’s materially inadequate internal systems and processes were adversely affecting its operations; (iii) the company’s inadequate systems and processes prevented it from ensuring reasonably accurate guidance and that its public disclosures were timely, accurate, and complete; (iv) as a result, defendants misrepresented DMC Global’s operations and financial results; and/or (v) as a result, the company’s public statements were materially false, misleading, or lacked a reasonable basis when made.

For more information on the DMC Global class action go to: https://bespc.com/cases/BOOM

Marqeta, Inc. (NASDAQ: MQ)

Class Period: May 7, 2024 - November 4, 2024

Lead Plaintiff Deadline: February 7, 2025

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Marqeta understated the regulatory challenges affecting its business outlook; (2) as a result, Marqeta would have to cut its guidance for the fourth quarter of 2024; and (3) as a result, defendants public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

For more information on the Marqeta class action go to: https://bespc.com/cases/MQ

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com